capillary hemangioblastoma
Jump to navigation
Jump to search
Etiology
- small number associated with von Hippel-Lindau disease
Epidemiology
- 7-10% of posterior fossa tumors
- 4% of spinal cord tumors
Pathology
- cerebellum most often involved (83%)
- also occurs in medulla (2%) & spinal cord (13%)
- occasionally multifocal
- often associated with or within a cyst & connected to meninges
Microscopic pathology
- reticular variant - uniformly distributed cells within intricate network of capillaries
- cellular variant - cells clustered forming groups separated by capillaries
- stromal cells
- irregular hyperchromatic nuclei
- eosinophilic, variably lipid rich, ill defined cytoplasm
- abundant glycogen
- mitoses absent or infrequent
- extramedullary erythropoiesis may be seen
Immunophenotype
Genetics
- inactivation of the vHL tumor suppressor gene
- some sporadic cases
- von Hippel-Lindau disease
Clinical manifestations
- may cause symptoms by compression of local neural structures
- symptoms depend on location; i.e cerebellar ataxia, motor weakness, sensory deficits
- pain may be a symptom
- bleeding may occur
- paraneoplastic syndrome may develop
Radiology
- magnetic resonance imaging (MRI) with gadolinium contrast
- enhancing mass frequently associated with a cyst
- smaller hemangiomas (< 10 mm) may be isointense on T1-weighted images & hyperintense on T2-weighted images
- angiography in conjunction with CT for patients who are not candidates for MRI
Complications
- compression of local neural structures
- spinal cord edema
- acute hemorrhage can be catastrophic
Differential diagnosis
Management
- tumors best managed by multidisciplinary team including
- neuroradiologist, radiation oncologist
- neurosurgeon
- neurooncologist
- preoperative angiogram
- embolization of feeding arteries may be indicated
- microspheres, ethanol
- intra-operative microscopic microdissection
- stereotactic radiosurgery (gamma-knife radiosurgery)
- conventional radiation therapy
- recurrence-free survival rates at 5,10 & 15 years are 76, 52 & 42%.